Concordance of Medicaid and pharmacy record data in inner-city children with asthma

Contemporary Clinical Trials

Volumn 29, Issue 1, 2008, Pages 13-20

  Mudd, Kim E ^a   Bollinger, Mary E ^b   Hsu, Van Doren ^c   Manning, Amanda ^a   Tsoukleris, Mona G ^c   Butz, Arlene M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Asthma; Claims analysis; Pediatrics; Study design

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; LEUKOTRIENE;

ANALYTIC METHOD; ARTICLE; ASTHMA; BILLING AND CLAIMS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL RECORD; PHARMACY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; COMMUNITY PHARMACY SERVICES; DATA COLLECTION; DRUG UTILIZATION; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICAID; PROSPECTIVE STUDIES; UNITED STATES; URBAN POPULATION;

EID: 36549049312     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2007.05.002     Document Type: Article

References (23)

1. Centers for Disease Control (CDC) National Center for Health Statistics, 2003http://www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma/asthma.htm.
2. Wilson S.E., Leonard A., Moomaw C., Schneeweiss S., and Eckman M.H. Underuse of controller medications among children with persistent asthma in the state of Ohio Medicaid populations: evolving differences with new medications. Ambul Pediatr 5 2 (2005) 83-89
3. Shields A.E., Comstock C., and Weiss K.B. Variations in asthma care by race/ethnicity among children enrolled in a state Medicaid program. Pediatrics 113 (2004) 496-504
4. Boudreaux E.D., Emond S.D., Clark S., and Camargo Jr. C.A. Race/ethnicity and asthma among children presenting to the emergency department: difference in disease severity and management. Pediatrics 111 (2003) 615-621
5. Akinbami L.J., LaFleur B.J., and Schoendorf K.C. Racial and income disparities in childhood asthma in the United States. Ambul Pediatr 2 5 (2002) 382-387
6. Finkelstein J.A., Lozano P., Farber H.J., Miroshnik I., and Lieu T.A. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med 156 6 (2002) 562-567
7. Castro M., Schechtman K.B., Halstead J., and Bloomberg G. Risk factors for asthma morbidity and mortality in a large metropolitan city. J Asthma 38 8 (2001) 625-635
8. Miller J.E. The effects of race/ethnicity and income on early childhood asthma prevalence and health care use. Am J Public Health 90 3 (2000) 428-430
9. Aligne C.A., Auinger P., Byrd R.S., and Weitzman M. Risk factors for pediatric asthma. Am J Respir Crit Care Med 162 (2000) 873-877
10. National Asthma Education and Prevention Program. The NAEPP Expert Panel Report: guidelines for the diagnosis and management of asthma-update on selected topics 2002. National Heart, Lung, and Blood Institute, National Institutes of Health publication no. 02-5075, Bethesda, MD (2002)
11. Lozano P., Finkelstein J.A., Hecht J., Shulruff R., and Weiss K.B. Asthma medication use and disease burden in children in a primary care population. Arch Pediatr Adolesc Med 157 1 (2003) 81-88
12. Bauman L.J., Wright E., Leickly F.E., Crain E., Kruszon-Moran D., Wade SL., et al. Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics 110 1 pt 1 (2002) e6
13. Lau H.S., de Boer A., Beuning K.S., and Porius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50 5 (1997) 619-625
14. Jones C., Santanello N.C., Boccuzzi S.J., Wogen J., Strub P., and Nelson L.M. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma 40 1 (2003) 93-101
15. Lukacs S.L., France E.F., Barón A.E., and Crane L.A. Effectiveness of an asthma management program for pediatric members of a large health maintenance organization. Arch Pediatr Adolesc Med 156 (2002) 872-876
16. Donahue J.G., Fuhlbrigge A.L., Finkelstein J.A., et al. Asthma pharmacotherapy and utilization by children in 3 managed care organizations. J Allergy Clin Immunol 106 6 (2000) 1109-1114
17. Zuckerman I.H., Stuart B., Magder L.S., Bollinger M.E., and Weiss S.R. Adherence to asthma treatment guidelines among children in the Maryland Medicaid program. Curr Ther Res 61 12 (2000) 912-924
18. Allen-Ramey F.C., Anstatt D.T., Sajjan S.G., and Markson L.E. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy. Pharmocotherapy 25 12 (2005) 1752-1760
19. Pawar V., and Smith M.J. Asthma-related healthcare services utilization by African-Americans enrolled in West Virginia Medicaid. Respir Med 100 9 (2006) 1578-1587
20. Dombkowski K.J., Wasilevich E.A., and Lyon-Callo S.K. Pediatric asthma surveillance using Medicaid claims. Public Health Rep 120 5 (2005) 515-524
21. Butz A.M., Tsoukleris M.G., Donithan M., et al. Effectiveness of nebulizer use targeted asthma education on underserved children with asthma. Arch Pediatr Adolesc Med 160 (2006) 622-628
22. Sherman J., Hudson A., Baumstein S., and Hendeles L. Telephoning the patient's pharmacy to assess adherence with asthma medications by measuring refill rates for prescriptions. J Pediatr 136 4 (2000) 532-536
23. Stuart B., Singhal P.K., Magder L.S., and Zuckerman I.H. How robust are health plan quality indicators to data loss? A Monte Carlo simulation study of pediatric asthma treatment. Health Serv Res 38 6 (2003) 1547-1561